mWIG40/ PL9999999912
PL9999999912| 1/3/2025 5:09:45 PM | Chg. +75.4 | Open | High | Low | Previous Close |
|---|---|---|---|---|---|
| 6,310.4PLN | +1.21% | 6,260.9 | 6,356.8 | 6,251.3 | 6,235.0 |
GlobeNewswire
12/11/2023
Ryvu Therapeutics Presents Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Me...
GlobeNewswire
12/7/2023
Ryvu Therapeutics Presents Data on RVU120 at the San Antonio Breast Cancer Symposium 2023
GlobeNewswire
11/29/2023
Ryvu Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
10/23/2023
Ryvu Therapeutics Provides an Update on the Progress of RVU120 Phase I Studies in Patients with Soli...
GlobeNewswire
10/4/2023
Ryvu Therapeutics to Present Preclinical Data on PRMT5 and its Synthetic Lethality Platform at the 2...
GlobeNewswire
9/13/2023
Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update